PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-100.00%
Both yoy net incomes decline, with 1097.HK at -515.27%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
20.08%
Some D&A expansion while 1097.HK is negative at -4.80%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
100.00%
Deferred tax of 100.00% while 1097.HK is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
12.14%
SBC growth of 12.14% while 1097.HK is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-637.42%
Negative yoy working capital usage while 1097.HK is 225.10%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
112.37%
Lower 'other non-cash' growth vs. 1097.HK's 999.72%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-9.43%
Negative yoy CFO while 1097.HK is 20.14%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-20.40%
Negative yoy CapEx while 1097.HK is 8.38%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
We reduce yoy sales while 1097.HK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
483.23%
Growth well above 1097.HK's 192.84%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-97.51%
We reduce yoy invests while 1097.HK stands at 7.16%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
59.42%
Debt repayment growth of 59.42% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
28231.38%
Issuance growth of 28231.38% while 1097.HK is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
100.00%
Similar buyback growth to 1097.HK's 100.00%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.